Joachim Morrens

524 total citations
19 papers, 318 citations indexed

About

Joachim Morrens is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joachim Morrens has authored 19 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joachim Morrens's work include Treatment of Major Depression (13 papers), Bipolar Disorder and Treatment (4 papers) and Tryptophan and brain disorders (4 papers). Joachim Morrens is often cited by papers focused on Treatment of Major Depression (13 papers), Bipolar Disorder and Treatment (4 papers) and Tryptophan and brain disorders (4 papers). Joachim Morrens collaborates with scholars based in Belgium, France and Portugal. Joachim Morrens's co-authors include Gerd Kempermann, Wim Van Den Broeck, Sebastian Haesler, Çağatay Aydın, Albino J. Oliveira‐Maia, Gianluca Rosso, Allan H. Young, Shanaya Rathod, Víctor Pérez and Christian Otte and has published in prestigious journals such as Neuron, Journal of Affective Disorders and Journal of the American Academy of Dermatology.

In The Last Decade

Joachim Morrens

16 papers receiving 313 citations

Peers

Joachim Morrens

PHARM

CMN

Adrienne N. Santiago United States

Yumiko Akamine Finland

Gaëlle Douillard‐Guilloux France

Feng-Chang Yen Taiwan

Antonia Dow United States

David Ladrón de Guevara‐Miranda Spain

Chin-Chuen Lin Taiwan

Magdalena M. Brzózka Germany

Gideon F. Meerhoff Netherlands

Sandra Beeské France

Adrienne N. Santiago United States

Joachim Morrens

54 ×0.5

PHARM

147 ×1.4

CMN

145 ×1.6

78 ×1.1

107 ×1.7

Citations per year, relative to Joachim Morrens Joachim Morrens (= 1×) peers Adrienne N. Santiago

Countries citing papers authored by Joachim Morrens

Since Specialization

Citations

This map shows the geographic impact of Joachim Morrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Morrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Morrens more than expected).

Fields of papers citing papers by Joachim Morrens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Morrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Morrens. The network helps show where Joachim Morrens may publish in the future.

Co-authorship network of co-authors of Joachim Morrens

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Morrens. A scholar is included among the top collaborators of Joachim Morrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Morrens. Joachim Morrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Morrens, Joachim, et al.. (2024). CO15 Real-World Treatment Usage of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Belgium: Results of the AREVEDECY Study. Value in Health. 27(12). S18–S18.

Oliveira‐Maia, Albino J., et al.. (2023). Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study. Frontiers in Psychiatry. 14. 1250987–1250987. 5 indexed citations

Ghislain, Pierre‐Dominique, et al.. (2023). 40351 Disease severity in moderate-to-severe plaque psoriasis: results from the Belgian REDISCOVER study. Journal of the American Academy of Dermatology. 89(3). AB37–AB37.

Oliveira‐Maia, Albino J., et al.. (2023). ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry. Frontiers in Psychiatry. 14. 1250980–1250980. 3 indexed citations

Morrens, Joachim, Maju Mathews, Vanina Popova, et al.. (2022). Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression. Neuropsychiatric Disease and Treatment. Volume 18. 1127–1132. 12 indexed citations

Oliveira‐Maia, Albino J., et al.. (2022). CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study. Value in Health. 25(12). S47–S47. 1 indexed citations

Heerlein, K., Thomas Frodl, Albino J. Oliveira‐Maia, et al.. (2021). Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization. Journal of Affective Disorders. 298(Pt A). 442–450. 22 indexed citations

Heerlein, K., Giulio Perugi, Christian Otte, et al.. (2021). Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes. Journal of Affective Disorders. 290. 334–344. 45 indexed citations

Oliveira‐Maia, Albino J., et al.. (2021). P.0226 Indirect comparison estimating the benefit of esketamine compared to distinct real-world treatment strategies for treatment resistant depression in general psychiatry. European Neuropsychopharmacology. 53. S163–S165. 1 indexed citations

10.

Perugi, Giulio, Sergio De Filippis, Gianluca Rosso, et al.. (2021). Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study. Frontiers in Psychiatry. 12. 769693–769693. 5 indexed citations

11.

Morrens, Joachim, et al.. (2021). P.0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis. European Neuropsychopharmacology. 53. S162–S163. 1 indexed citations

12.

MacIntyre, Donald J., et al.. (2021). Treatment resistant depression in the UK: sub-analysis of a European real-world evidence study. BJPsych Open. 7(S1). S55–S55. 1 indexed citations

13.

Morrens, Joachim, et al.. (2020). PND1 USE OF CLINICAL GLOBAL IMPRESSIONS-SEVERITY (CGI-S) TO ASSESS RESPONSE TO ANTIDEPRESSANT TREATMENT IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. Value in Health. 23. S258–S258.

14.

Heerlein, K., Allan H. Young, Christian Otte, et al.. (2020). Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics. Journal of Affective Disorders. 283. 115–122. 34 indexed citations

15.

Morrens, Joachim, et al.. (2020). Cue-Evoked Dopamine Promotes Conditioned Responding during Learning. Neuron. 106(1). 142–153.e7. 59 indexed citations

16.

Croubels, Siska, et al.. (2020). Simultaneous Measurement of Glomerular Filtration Rate, Effective Renal Plasma Flow and Tubular Secretion in Different Poultry Species by Single Intravenous Bolus of Iohexol and Para-Aminohippuric Acid. Animals. 10(6). 1027–1027. 7 indexed citations

17.

Gasthuys, Elke, et al.. (2019). Development of an in Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (Nymphicus hollandicus). Journal of Avian Medicine and Surgery. 33(4). 349–349. 4 indexed citations

18.

Morrens, Joachim, et al.. (2019). PMH44 INCREASED USE OF AUGMENTATION THERAPIES ILLUSTRATES COMPLEX MANAGEMENT OF TREATMENT RESISTANT DEPRESSION. PRELIMINARY RESULTS FROM A REAL-WORD EVIDENCE REGISTRY IN EUROPE, THE 54135419DEP4001 STUDY. Value in Health. 22. S688–S688. 1 indexed citations

19.

Morrens, Joachim, Wim Van Den Broeck, & Gerd Kempermann. (2011). Glial cells in adult neurogenesis. Glia. 60(2). 159–174. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact